[1] Chen YC,Rivera J,Peter K.Tandem stenosis to induce atherosclerotic plaque instability in the mouse[J].Methods Mol Biol,2015,1339(1):333-338.[2] Ahmadi A,Leipsic J,Blankstein R,et al. Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression[J].Circ Res,2015,117(1):99-104.[3] Figg NL,Bennett MR.Quantification of apoptosis in mouse atherosclerotic lesions[J]. Methods Mol Biol,2015,1339:191-199.[4] 常立萍,邢笑佳,邓悦.伏邪理论指导治疗血管重建术后冠状动脉粥样硬化性心脏病临床疗效研究[J].环球中医药,2012,5(9):669-672.[5] 郭家娟,王策,崔英子,等. 参红化浊通络颗粒治疗冠心病心绞痛的疗效[J].中国老年学杂志,2013,33(8):1755-1756.[6] 常立萍,尹金珠,王义强,等.参红通络颗粒治疗冠心病稳定型心绞痛[J].吉林中医药, 2013,35(12):44-46.[7] 陈颖,邓悦,崔英子,等.基于痰瘀伏邪病因的中医药干预稳定性心绞痛的方案研究[J].辽宁中医杂志, 2013,40(5):939-940.[8] 李智燕.益气活血化痰方抗细胞凋亡防治动脉粥样硬化的机制研究[D].长春:长春中医药大学,2015.[9] 陈颖,李松. 实验性"痰淤伏邪"模型病理演变规律及中药干预作用研究[J].长春中医药大学学报, 2013,35(2):36-39.[10] 杨跃进,华伟.阜外心血管内科手册[M].北京:人民卫生出版社,2013:106-107.[11] Eenovefa K,Vana K,Spohie M. Lipidomics in vascular health:current perspectives[J].Vasc Health Risk Manag,2015,11(1):333-342.[12] Feig JE,Feig JL,Kini AS. Statins, atherosclerosis regression and HDL:Insights from within the plaque[J].Int J Cardiol,2015,189(1):168-171.[13] 左伋.医学分子细胞生物学[M].上海:复旦大学出版社,2005:224-226.[14] Lee EK,Jung KJ,Choi J,et al.Molecular basis for age-related changes in ileum:involvement of Bax/caspase-dependent mitochondrial apoptotic signaling[J].Exp Gerontol,2010,45(12):970-976.[15] 李欣,栗印军.血压变异性与动脉粥样硬化病变程度相关性研究进展[J].中国实用内科杂志,2014,34(增2):59-61.[16] 毕晶,胥朝辉,陈晓群.彩色多普勒超声在下肢动脉粥样硬化性闭塞症的诊断价值[J].中国实用内科杂志,2014,34(增1):103-104. |